FDA Cites Florida Drugmaker for Serious Quality Violations

Drug Industry Daily
A A
An FDA investigation into serous quality problems at a Florida pharmaceutical company revealed a litany of unsound practices in the manufacture of experimental drugs.

To View This Article:

Login

Subscribe To Drug Industry Daily